Candriam SCA’s Summit Therapeutics SMMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$10.9M	Sell	513,763 -324,755	-39%	-$6.91M	0.06%	242
2025 Q1	$16.2M	Sell	838,518 -4,033	-0.5%	-$77.8K	0.1%	183
2024 Q4	$15M	Sell	842,551 -7,852	-0.9%	-$140K	0.09%	209
2024 Q3	$18.6M	Buy	+850,403	New	+$18.6M	0.11%	191